Publications
464
Citations
13,830
Est. group size
—
Recurring co-author estimate
Active years
49
Publishing since 1978
Andrew A. House works in nephrology (kidney disease and treatment), with particular focus on kidney transplantation, acute kidney injury, dialysis-related therapies, and genetic testing for chronic kidney disease. Recent work also includes studies on tuberous sclerosis complex (a genetic disorder affecting multiple organs, including the kidneys) and its associated kidney tumors. This research combines clinical outcomes studies, registry-based data analysis, and genetic and biomarker research relevant to kidney patients.
Publication output has grown somewhat unevenly over the last decade, rising from about 5 papers in 2017 to a peak of 14 in 2025, suggesting an overall increasing trend despite year-to-year fluctuation.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Genetic testing in kidney transplantation and living kidney donor risk assessment
Kidney International · 2026
- Association between obesity and kidney outcomes in critically ill patients with acute kidney injury receiving continuous renal replacement therapy: a secondary analysis of the multicenter CRRTnet study
Critical Care · 2026
- External Validation and Recalibration of a Risk Calculator for Major Bleeding After Diagnostic Kidney Biopsy
Kidney Medicine · 2026
- Renal cell carcinoma with fibromyomatous stroma (<scp>RCC FMS</scp>) and with hemangioblastoma‐like areas is part of the <scp>RCC FMS</scp> spectrum in patients with tuberous sclerosis complex
Histopathology · 2025
- Distinct peripheral pro‐inflammatory profile associated with tuberous sclerosis complex and epilepsy
Epilepsia · 2025
- Anionic Citrate‐Based 3D‐Printed Scaffolds for Tunable and Sustained Orthobiologic Delivery to Enhance Tissue Regeneration
Advanced Functional Materials · 2025
- Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada
Frontiers in Immunology · 2025
- 766 Renal Cell Carcinoma with Fibromyomatous Stroma (RCC FMS) with Hemangioblastoma (HB)-like Areas is Part of the Morphologic Spectrum of RCC FMS in Patients with Tuberous Sclerosis Complex
Laboratory Investigation · 2025
- Genetic Testing in Adults over 50 Years with Chronic Kidney Disease: Diagnostic Yield and Clinical Implications in a Specialized Kidney Genetics Clinic
Genes · 2025
- Evaluating Real-World Data of CRRT Dose Prescription: Results from the CRRTnet Registry
Journal of the American Society of Nephrology · 2025
- Cellular Alignment and Matrix Stiffening Induced Changes in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (Adv. Healthcare Mater. 6/2025)
Advanced Healthcare Materials · 2025
- The Current State of Care for Tuberous Sclerosis Complex in Canada
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025
- Signaling Pathways Shaping the Field of Lipidomics
Preprints.org · 2025
- Blood Biomarkers to Identify Renal Angiomyolipomas in People With Tuberous Sclerosis Complex
Neurology Genetics · 2025
- Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada
Frontiers in Immunology · 2025
- Canadian Journal of Kidney Health and Disease×7
- Elsevier eBooks×6
- Journal of the American Society of Nephrology×4
- American Journal of Kidney Diseases×4
- Clinical Transplantation×4
- Hiren P. Patel
Medicine · The Ohio State University
- Brent W. Miller
Medicine · Indiana University
- William R. Clark
Medicine · Purdue University West Lafayette
- Michael A. Kraus
Medicine · Indiana University
- Kausik Umanath
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile